- Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study2024 | 2. lékařská fakulta
- Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation2020 | Publikace bez příslušnosti k fakultě
- Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment2015 | Lékařská fakulta v Plzni
- HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation2014 | Lékařská fakulta v Plzni
- Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius2011 | Ústřední knihovna
- Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation2014 | Publikace bez příslušnosti k fakultě
- Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study2020 | 2. lékařská fakulta
- Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes2018 | 2. l ékařská fakulta
- Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion2018 | Publikace bez příslušnosti k fakultě
- Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome2019 | 1. lékařská fakulta
- Prognostic Factors Affecting Outcome after Allogeneic Transplantation for Hematological Malignancies from Unrelated Donors: Results from a Randomized Trial2012 | Lékařská fakulta v Hradci Králové
- Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation2012 | Ústřední knihovna
- Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases2017 | 3. lékařská fakulta
- Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma2018 | Lékařská fakulta v Hradci Králové
- Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation2015 | Publikace bez příslušnosti k fakultě
- Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation2017 | 2. lékařská fakulta
- Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome2019 | Lékařská fakulta v Plzni
- Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission2018 | Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study2019 | 2. lékařská fakulta